Target intelligence / Profile preview

CEA cell adhesion molecule pseudogene 2 (CEACAMP2)

Target
CEACAMP2
Molecular classification
Other, Pseudogene
01

Overview

CEA cell adhesion molecule pseudogene 2 (CEACAMP2) is a member of the carcinoembryonic antigen (CEA)-related cell adhesion molecule (CEACAM) gene family, but it is classified as a **pseudogene**, meaning it does not encode a functional protein. Pseudogenes arise from gene duplication or retrotransposition events and usually bear high sequence similarity to protein-coding genes but are rendered non-functional by mutations, deletions, or lack of regulatory elements. As a pseudogene, CEACAMP2 is not considered a therapeutic target, does not have established biological functions or disease relevance, and has no known interactions with drugs or roles as a biomarker. There is nothing to suggest from the biomedical literature that CEACAMP2 is involved in any disease mechanisms or therapeutic pathways relevant to the functional CEACAM proteins such as CEACAM1, CEACAM5, or CEACAM6. Its inclusion as a target is likely due to an error, confusion with related functional proteins, or automated extraction from gene lists.

Other names
CEACAMP2CEA cell adhesion molecule pseudogene 2
02

Biological functions

Other
03

Disease associations

Other

Beyond the preview

Go deeper on CEA cell adhesion molecule pseudogene 2 (CEACAMP2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on CEA cell adhesion molecule pseudogene 2 (CEACAMP2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call